Patterson Companies (PDCO)
(Delayed Data from NSDQ)
$21.05 USD
+0.25 (1.20%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $21.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$21.05 USD
+0.25 (1.20%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $21.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Zacks News
Merit Medical (MMSI) Looks Good: Stock Adds 6.7% in Session
by Zacks Equity Research
Merit Medical (MMSI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Top Ranked Growth Stocks to Buy for July 15th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 15th.
4 Best MedTech Stocks to Combat Coronavirus Crisis on Strong ROE
by Debanjana Dey
Here are some MedTech stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.
Top Ranked Growth Stocks to Buy for July 14th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 14th.
3 Growth-Focused MedTech Stocks to Buy Amid Coronavirus Crisis
by Sriparna Ghosal
Once the pandemic-led crisis is over, these MedTech growth-focused stocks will flourish on a number of positive developments.
Walgreens Boots (WBA) Q3 Earnings Lag Estimates, Margin Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal third-quarter results reflect overall top line improvement despite COVID-19-led business disruptions.
Is Patterson Cos. (PDCO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: Sprouts Farmers Market, Patterson Companies, Sleep Number, T-Mobile US and Quest Diagnostics
by Zacks Equity Research
Zacks.com featured highlights include: Sprouts Farmers Market, Patterson Companies, Sleep Number, T-Mobile US and Quest Diagnostics
3 GARP MedTech Stocks to Beat Pandemic-Led Market Volatility
by Trina Mukherjee
Here we look at three stocks that investors can add to their watchlist backed by robust long-term prospects.
Top Ranked Growth Stocks to Buy for July 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 9th.
Why Patterson (PDCO) Could Be Positioned for a Surge
by Zacks Equity Research
Patterson (PDCO) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
5 Stocks With Relative Price Strength to Enhance Your Returns
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Top Ranked Growth Stocks to Buy for July 7th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 7th.
New Strong Buy Stocks For July 7th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
3 Cheap MedTech Stocks Set to Gain Once Coronavirus Crisis Ebbs
by Sriparna Ghosal
Once the pandemic-led crisis eases, these MedTech stocks will likely flourish on the back of number of positive developments.
PDCO vs. CNMD: Which Stock Is the Better Value Option?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Patterson Companies' Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Patterson Companies.
Earnings Estimates Moving Higher for Patterson Cos. (PDCO): Time to Buy?
by Zacks Equity Research
Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
4 Cheap MedTech Stocks Poised to Beat Industry Post-Pandemic
by Debanjana Dey
Here are some MedTech stocks which might be a solid investment option post the coronavirus blues.
Patterson Companies (PDCO) Q4 Earnings Top Estimates, Up Y/Y
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal fourth-quarter results reflect dismal performance by Dental and Animal Health segments.
What's in Store for Patterson Companies' (PDCO) Q4 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal fourth-quarter results are likely to reflect solid performance at Dental segment.
Near-Term Outlook Bleak for Medical Dental Supplies Industry
by Trina Mukherjee
Digital influence coupled with AI & Robotics can drive the medical dental supplies industry amid the coronavirus-induced crisis.
Earnings Preview: Patterson Cos. (PDCO) Q4 Earnings Expected to Decline
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Patterson Cos. (PDCO) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Patterson Cos. (PDCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Invest in McKesson (MCK) Stock Now
by Zacks Equity Research
McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.